COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,547 Articles (22,881 medRxiv, 8,666 bioRxiv)

Most recent first Previous |  Page 674: Articles 6731-6740  | Next

Scaling rules for pandemics: Estimating infected fraction from identified cases for the SARS-CoV-2 Pandemic
Ma, M., Zsolway, M., Tarafder, A., Bhanot, G.
10.1101/2022.09.05.22279599 — Posted: 2022-09-06
Community engagement to increase vaccine uptake: Quasi-experimental evidence from Islamabad and Rawalpindi, Pakistan
Abdullah, M., Ahmad, T., Kazmi, T., Sultan, F., Afzal, S., Safdar, R. M., Khan, A. A.
10.1101/2022.09.04.22279583 — Posted: 2022-09-06
The prevalence of SARS-CoV-2 infection and long COVID in US adults during the BA.5 surge, June-July 2022
Qasmieh, S., Robertson, M., Teasdale, C. A., Kulkarni, S., Jones, H. E., McNairy, M., Borrell, L. N., Nash, D.
10.1101/2022.09.04.22279588 — Posted: 2022-09-06
Mucosal immunity and antibody anergy in COVID-exposed Covishield vaccinees
Kannian, P., Mahanathi, P., Gracemary, A., Kumarasamy, N., Challacombe, S. J.
10.1101/2022.09.06.22279625 — Posted: 2022-09-06
Persistent somatic symptoms are key to individual illness perception at one year after COVID-19
Hüfner, K., Tymoszuk, P., Sahanic, S., Luger, A., Boehm, A., Pizzini, A., Schwabl, C., Koppelstätter, S., Kurz, K., Asshoff, M., Mosheimer-Feistritzer, B., Pfeifer, B., Rass, V., Schroll, A., Iglseder, S., Egger, A., Wöll, E., Weiss, G., Helbok, R., Widmann, G., Sonnweber, T., Tancevski, I., Sperner-Unterweger, B., Löffler-Ragg, J.
10.1101/2022.09.05.22279602 — Posted: 2022-09-06
Advanced Care Planning (ACP) in the early phase of COVID-19: A rapid review of the practice and policy lessons learned.
Younan, S., Cardona, M., Sahay, A., Willis, E., Ni Chroinin, D.
10.1101/2022.09.05.22278731 — Posted: 2022-09-06
Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo.
de Antonellis, P., Ferrucci, V., Bibbo, F., Asadzadeh, F., Gorini, F., Boccia, A., Sorice, C., Siciliano, R., Russo, R., Andolfo, I., Lasorsa, V. A., Cantalupo, S., Paolella, G., Fusco, G., Viscardi, M., Brandi, S., Pierri, B., Cerino, P., Monaco, V., Choi, D. R., Cheong, J.-H., Monti, M., Iolascon, A., Amente, S., Capasso, M., Kim, H. Y., Zollo, M.
10.1101/2022.09.02.22279542 — Posted: 2022-09-06
Optimization and deoptimization of codons in SARS-CoV-2 and the implications for vaccine development
Wu, X., Shan, K., Zan, F., Tang, X., Qian, Z., Lu, J.
10.1101/2022.09.03.506470 — Posted: 2022-09-05
Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
Rosenke, K., Lewis, M., Feldmann, F., Bohrnsen, E., Schwarz, B., Okumura, A., Bohler, W. F., Callison, J., Shaia, C., Bosio, C., Lovaglio, J., Saturday, G., Jarvis, M., Feldmann, H.
10.1101/2022.09.03.506479 — Posted: 2022-09-05
Delayed SARS-CoV-2 Spread and Olfactory Cell Lineage Impairment in Close-Contact Infection Syrian Hamster Models
Ueha, R., Ito, T., Ueha, S., Furukawa, R., Kitabatake, M., Ouji-Sageshima, N., Uranaka, T., Tanaka, H., Nishijima, H., Kondo, K., Yamasoba, T.
10.1101/2022.09.03.506499 — Posted: 2022-09-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).